Sung Soo Mun - Concepedia

Author

Sung Soo Mun

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

Sung S. Mun, Sung Soo Mun, Sungsoo Mun

Publications

330

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Cornell University Weill Cornell Medicine Eureka Therapeutics (United States)Kettering University

About

Sung Soo Mun is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, immunology, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	117
2	Cell Biology	3	3	75
3	Engineering	1	1	19
4	Biochemistry	1	1	31
5	Biomolecular Engineering	1	1	19

Sung Soo Mun

Publications

301

Citations

H-Index

Page 1

	Year	Citations
ALK and RET Inhibitors Promote HLA Class I Antigen Presentation and Unmask New Antigens within the Tumor Immunopeptidome Claire Y. Oh, Martin G. Klatt, Christopher M. Bourne, Cancer Immunology Research	2019	49
Bispecific antibodies promote natural killer cell-mediated elimination of HIV-1 reservoir cells Nathan L. Board, Zhe Yuan, Fengting Wu, Nature Immunology	2024	38
Solving an MHC allele–specific bias in the reported immunopeptidome Martin G. Klatt, Kyeara N. Mack, Yang Bai, JCI Insight Mhc Allele–specific BiasImmunologyAntigen ProcessingPeptide ScienceImmune System	2020	31
Dual targeting ovarian cancer by Muc16 CAR T cells secreting a bispecific T cell engager antibody for an intracellular tumor antigen WT1 Sung Soo Mun, Jeremy Meyerberg, Leila Peraro, Cancer Immunology Immunotherapy Tumor ImmunologyCancer ImmunosurveillanceImmunologyImmune Checkpoint InhibitorAntigen Processing	2023	29
Low-dose CDK4/6 inhibitors induce presentation of pathway specific MHC ligands as potential targets for cancer immunotherapy Angel Charles, Christopher M. Bourne, Tanya Korontsvit, OncoImmunology New LigandsRadiation OncologyCancer ImmunosurveillanceHla LigandsReceptor Tyrosine Kinase	2021	27
Depleting T regulatory cells by targeting intracellular Foxp3 with a TCR mimic antibody Tao Dao, Sung Soo Mun, Andrew Scott, OncoImmunology	2019	25
A dual-receptor T-cell platform with Ab-TCR and costimulatory receptor achieves specificity and potency against AML Tao Dao, Guangyan Xiong, Sung Soo Mun, Blood	2023	23
A TCR mimic CAR T cell specific for NDC80 is broadly reactive with solid tumors and hematologic malignancies Martin G. Klatt, Tao Dao, Zhiyuan Yang, Blood	2022	20
A TCR mimic monoclonal antibody reactive with the “public” phospho-neoantigen pIRS2/HLA-A*02:01 complex Tao Dao, Sung Soo Mun, Zaki Molvi, JCI Insight EngineeringMhc ClassImmunologyPathologyAntigen Processing	2022	19
Unmasking the suppressed immunopeptidome of EZH2-mutated diffuse large B-cell lymphomas through combination drug treatment Christopher M. Bourne, Sung Soo Mun, Tao Dao, Blood Advances	2022	16

Page 1